NEW YORK - The world-wide publicity generated by a photo of a patient's tattooed genitalia snapped by a surgeon during an operation has prompted drug giant Pfizer to realize it is missing out on a valuable medium to advertise to doctors."After years of spending millions of dollars on ads in medical journals and 60-second TV spots, we've concluded we get zero bang for our buck," said Bradleys Roadhouse, spokesman for Pfizer. "To get the doctors' attention, we need to get our name on penises."
Pfizer joins GlaxoSmithKline, Hoffman-LaRoche and Wyeth in doing direct-to-physician penis advertising.
Pfizer had been hesitant about jumping on the penis bandwagon but was pushed over the edge by the buzz created when the Mayo Clinic's Dr. Adam Hansen admitted taking a photo of a patient's penis with a tattoo that reads "Hot Rod" and showing it around to other doctors. The incident created an international sensation.
Pfizer would not reveal what it plans to pay the men who advertise for it but noted that "obviously the more media space we buy, the greater the value to us. In other words, sorry, guys, size matters."
Pfizer had been hesitant about jumping on the penis bandwagon but was pushed over the edge by the buzz created when the Mayo Clinic's Dr. Adam Hansen admitted taking a photo of a patient's penis with a tattoo that reads "Hot Rod" and showing it around to other doctors. The incident created an international sensation.
Pfizer would not reveal what it plans to pay the men who advertise for it but noted that "obviously the more media space we buy, the greater the value to us. In other words, sorry, guys, size matters."
